Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Dec;17(12):1316-27.
doi: 10.1038/mp.2011.125. Epub 2011 Oct 18.

Genome-wide association study of Alzheimer's disease with psychotic symptoms

Collaborators, Affiliations
Meta-Analysis

Genome-wide association study of Alzheimer's disease with psychotic symptoms

P Hollingworth et al. Mol Psychiatry. 2012 Dec.

Abstract

Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysis of three genome-wide association studies (GWASs) to identify loci that (1) increase susceptibility to an AD and subsequent psychotic symptoms; or (2) modify risk of psychotic symptoms in the presence of neurodegeneration caused by AD. In all, 1299 AD cases with psychosis (AD+P), 735 AD cases without psychosis (AD-P) and 5659 controls were drawn from Genetic and Environmental Risk in AD Consortium 1 (GERAD1), the National Institute on Aging Late-Onset Alzheimer's Disease (NIA-LOAD) family study and the University of Pittsburgh Alzheimer Disease Research Center (ADRC) GWASs. Unobserved genotypes were imputed to provide data on >1.8 million single-nucleotide polymorphisms (SNPs). Analyses in each data set were completed comparing (1) AD+P to AD-P cases, and (2) AD+P cases with controls (GERAD1, ADRC only). Aside from the apolipoprotein E (APOE) locus, the strongest evidence for association was observed in an intergenic region on chromosome 4 (rs753129; 'AD+PvAD-P' P=2.85 × 10(-7); 'AD+PvControls' P=1.11 × 10(-4)). SNPs upstream of SLC2A9 (rs6834555, P=3.0 × 10(-7)) and within VSNL1 (rs4038131, P=5.9 × 10(-7)) showed strongest evidence for association with AD+P when compared with controls. These findings warrant further investigation in larger, appropriately powered samples in which the presence of psychotic symptoms in AD has been well characterized.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatterplot of chromosomal position (x-axis) against –log 10 GWAS P-value (yaxis). a) AD+P vs Controls, b) AD+P vs AD−P. The threshold for genome-wide significance (p ≤ 9.5×10−8) is indicated by the red horizontal line. The y-axis scale has been limited to 10 (P = 1 × 10−10), although highly significant association was observed with SNPs in the vicinity of the APOE locus when comparing AD+P cases with controls. Plots produced using Haploview v4.0 (http://www.broad.mit.edu/mpg/haploview/).

References

    1. Hollingworth P, Harold D, Jones L, Owen MJ, Williams J. Alzheimer's disease genetics: current knowledge and future challenges. Int J Geriatr Psychiatry. 2010 - PubMed
    1. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41(10):1088–1093. - PMC - PubMed
    1. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet. 2010;19(16):3295–3301. - PMC - PubMed
    1. Zhang Q, Yu JT, Zhu QX, Zhang W, Wu ZC, Miao D, et al. Complement receptor 1 polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 2010 - PubMed
    1. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol. 2010;67(8):961–964. - PMC - PubMed

Publication types

MeSH terms

Grants and funding